ArticleOncotarget2016

Synthetic low-density lipoprotein (sLDL) selectively delivers paclitaxel to tumor with low systemic toxicity.

Hai-Tao Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.